New and efficient synthesis of 5′-amino-5′-(S)-methyl-2′,5′-dideoxynucleosides

Tetrahedron Letters

Volumn 44, Issue 2, 2003, Pages 293-297

  Jung, Pierre M J ^a   Beaudegnies, Renaud ^a   De Mesmaeker, Alain ^a   Wendeborn, Sebastian ^a  

^a SYNGENTA CROP PROTECTION AG   (Switzerland)

Author keywords

5 amino 5 (S) methyl 2 , 5 dideoxynucleosides; Nucleophilic addition; Tert butylsulfinamide

Indexed keywords

AMIDE; BROMINE DERIVATIVE; LITHIUM; MAGNESIUM; NUCLEOSIDE DERIVATIVE;

ARTICLE; DIASTEREOISOMER; NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; SYNTHESIS;

EID: 0037421032     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(02)02514-5     Document Type: Article

References (28)

1. For examples, see: Hélène, C. Anti-Cancer Drug Des. 1991, 6, 569-584 and references cited therein; Fox, K. R. Curr. Med. Chem. 2000, 7, 17-37; Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543; De Mesmaeker, A.; Häner, A.; Martin P. Moser, H. E. Acc. Chem. Res. 1995, 28, 366-374 and references cited therein.
2. For examples, see: Hélène, C. Anti-Cancer Drug Des. 1991, 6, 569-584 and references cited therein; Fox, K. R. Curr. Med. Chem. 2000, 7, 17-37; Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543; De Mesmaeker, A.; Häner, A.; Martin P. Moser, H. E. Acc. Chem. Res. 1995, 28, 366-374 and references cited therein.
3. For examples, see: Hélène, C. Anti-Cancer Drug Des. 1991, 6, 569-584 and references cited therein; Fox, K. R. Curr. Med. Chem. 2000, 7, 17-37; Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543; De Mesmaeker, A.; Häner, A.; Martin P. Moser, H. E. Acc. Chem. Res. 1995, 28, 366-374 and references cited therein.
4. For examples, see: Hélène, C. Anti-Cancer Drug Des. 1991, 6, 569-584 and references cited therein; Fox, K. R. Curr. Med. Chem. 2000, 7, 17-37; Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543; De Mesmaeker, A.; Häner, A.; Martin P. Moser, H. E. Acc. Chem. Res. 1995, 28, 366-374 and references cited therein.
5. De Mesmaeker A., Waldner A., Fritsch V., Wolf R.M., Freier S.M. Tetrahedron Lett. 34:1993;6383-6386.
6. De Mesmaeker A., Waldner A., Lebreton J., Hoffmann P.A., Fritsch V., Wolf R.M., Freier S. Angew. Chem., Int. Ed. Engl. 33:1994;226-229.
7. Lebreton J., Waldner A., Lesueur C., De Mesmaeker A. Synlett. 1994;137-140.
8. Lebreton J., Waldner A., Fritsch V., Wolf R.M., De Mesmaeker A. Tetrahedron Lett. 35:1994;5225-5228.
9. De Mesmaeker A., Lebreton J., Waldner A., Fritsch V., Wolf R.M. Biorg. Med. Chem. Lett. 4:1994;873-878.
10. Fritsch V., De Mesmaeker A., Waldner A., Lebreton J., Blommers M.J.J., Wolf R.M. Biorg. Med. Chem. 3:1995;321-335.
11. Waldner A., De Mesmaeker A., Wendeborn S. Biorg. Med. Chem. Lett. 6:1996;2363-2366.
12. De Mesmaeker A., Lesueur C., Bévièrre M.-O., Waldner A., Fritsch V., Wolf R.M. Angew. Chem., Int. Ed. Engl. 35:1996;2790-2794.
13. DeMesmaeker A., Juanno C., Wolf R.M., Wendeborn S. Biorg. Med. Chem. Lett. 7:1997;447-452.
14. De Mesmaeker A., Wendeborn S., Juanno C., Fritsch V., Wolf R.M. Bioorg. Med. Chem. Lett. 7:1997;1869-1874.
15. Wolf R.M., DeMesmaeker A., Wendeborn S., Waldner A., Fritsch V., Lebreton J. New J. Chem. 21:1997;61-72.
16. De Mesmaeker A., Lebreton J., Juanno C., Fritsch V., Wolf R.M., Wendeborn S. Synlett. 1997;1287-1290.
17. For example: Liu, G.; Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc. 1997, 119, 9913; Cogan, D. A.; Liu, G.; Ellman, J. A. Tetrahedron, 1999, 55, 8883.
18. For example: Liu, G.; Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc. 1997, 119, 9913; Cogan, D. A.; Liu, G.; Ellman, J. A. Tetrahedron, 1999, 55, 8883.
19. For examples, see: O-Yang, C.; Wu, H. Y.; Fraser-Smith, E. B.; Walker, K. A. M. Tetrahedron Lett. 1992 33, 37-40; Bar, N. C.; Patra, R.; Basudeb, S.; Mandal, B. Tetrahedron 1997, 53, 4727-4738; Foeldesi, A.; Maltseva, T. V.; Chattopadhyaya, J. Nucleosides Nucleotides 1999, 18, 1377-1378.
20. For examples, see: O-Yang, C.; Wu, H. Y.; Fraser-Smith, E. B.; Walker, K. A. M. Tetrahedron Lett. 1992 33, 37-40; Bar, N. C.; Patra, R.; Basudeb, S.; Mandal, B. Tetrahedron 1997, 53, 4727-4738; Foeldesi, A.; Maltseva, T. V.; Chattopadhyaya, J. Nucleosides Nucleotides 1999, 18, 1377-1378.
21. For examples, see: O-Yang, C.; Wu, H. Y.; Fraser-Smith, E. B.; Walker, K. A. M. Tetrahedron Lett. 1992 33, 37-40; Bar, N. C.; Patra, R.; Basudeb, S.; Mandal, B. Tetrahedron 1997, 53, 4727-4738; Foeldesi, A.; Maltseva, T. V.; Chattopadhyaya, J. Nucleosides Nucleotides 1999, 18, 1377-1378.
22. 3); 1.71 (1H, m, H-2′); 1.04 (9H, s, tBu).
23. Cogan D.A., Liu G., Ellman J. Tetrahedron. 55:1999;8883-8904.
24. Davis F.A., McCoull W. J. Org. Chem. 64:1999;3396-3397.
25. See for example: Eppacher, S.; Solladié, N.; Bernet, B.; Vasella, A. Helv. Chim. Acta 2000, 83, 1311; Czernecki, S.; Valéry, J.-M. J. Carbohydr. Chem. 1988, 7, 151; Barrow, J. C.; Ngo, P. L.; Pellicore, J. M.; Selnick, H. G.; Nantermet, P. G. Tetrahedron Lett. 2001, 42, 2051-2054.
26. See for example: Eppacher, S.; Solladié, N.; Bernet, B.; Vasella, A. Helv. Chim. Acta 2000, 83, 1311; Czernecki, S.; Valéry, J.-M. J. Carbohydr. Chem. 1988, 7, 151; Barrow, J. C.; Ngo, P. L.; Pellicore, J. M.; Selnick, H. G.; Nantermet, P. G. Tetrahedron Lett. 2001, 42, 2051-2054.
27. See for example: Eppacher, S.; Solladié, N.; Bernet, B.; Vasella, A. Helv. Chim. Acta 2000, 83, 1311; Czernecki, S.; Valéry, J.-M. J. Carbohydr. Chem. 1988, 7, 151; Barrow, J. C.; Ngo, P. L.; Pellicore, J. M.; Selnick, H. G.; Nantermet, P. G. Tetrahedron Lett. 2001, 42, 2051-2054.
28. 3, 7 Hz).